Thrixen was founded by international scientists from multidisciplinary areas from Singapore and USA in 2021. Through many years of research, we have created a set of proprietary technologies that revolutionize biomarker detection and rapid assay generation.
At Thrixen we are developing a diagnostic technology platform to make diagnostics available when and where they matter most. Our proprietary engineered protein binders combined with a unique assay format allow us bring essential diagnostics closer to the patients, affordably and at scale.
Get In Touch
Get in touch with us to learn more about what we are working on or to discuss collaboration opportunities.